# The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.

> **NCT00171457** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 24 (—)

## Conditions studied

- Heartburn
- Dyspepsia

## Interventions

- **DRUG:** Tegaserod

## Key facts

- **NCT ID:** NCT00171457
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 24 (—)
- **Last updated:** 2007-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171457, "The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00171457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*